John T. Lawler is with AbbVie Inc., Small Molecule Analytical R&D Department of AbbVie Inc., in North Chicago, Illinois.
A Standardized 2D-LC Screening Platform for Peak Purity Determination in Pharmaceutical Analysis
June 1st 2023This study suggests a 2D-LC screening method to evaluate peak purity and ensure specificity in pharmaceutical analysis, thereby promoting the safe production of medicines by detecting active pharmaceutical ingredients (API) and related substances.